Get the Stockscreener App
22.81
1.47%
0.33
After Hours:
22.81
Overview
News
Price History
Option Chain
Why FMS Down?
Discussions
Forecast
Stock Split
Dividend History
Fresenius Medical Care Ag Adr stock is traded at $22.81, with a volume of 405.51K.
It is up +1.47% in the last 24 hours and up +4.68% over the past month.
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
See More
Previous Close:
$22.48
Open:
$22.62
24h Volume:
405.51K
Relative Volume:
1.53
Market Cap:
$13.39B
Revenue:
$20.87B
Net Income/Loss:
$715.14M
P/E Ratio:
27.97
EPS:
0.8156
Net Cash Flow:
$1.67B
1W Performance:
-3.55%
1M Performance:
+4.68%
6M Performance:
+16.73%
1Y Performance:
+11.32%
1-Day Range:
$22.45
$22.89
1-Week Range:
$22.43
$24.07
52-Week Range:
$17.93
$24.31
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Name
Fresenius Medical Care Ag Adr
Sector
Industry
Phone
-
Address
-
Compare FMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
22.81 | 13.39B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
HCA
Hca Healthcare Inc
|
303.62 | 76.91B | 69.62B | 5.93B | 5.88B | 22.27 |
|
DVA
Davita Inc
|
151.85 | 12.46B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
129.46 | 12.31B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
180.11 | 11.88B | 15.42B | 1.03B | 956.84M | 15.02 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-06-24 | Initiated | Berenberg | Buy |
| Jan-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-24-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-17-23 | Upgrade | Societe Generale | Hold → Buy |
| Aug-14-23 | Downgrade | UBS | Buy → Neutral |
| Aug-01-23 | Resumed | Citigroup | Neutral |
| Jul-12-23 | Initiated | Goldman | Buy |
| Mar-07-23 | Initiated | Bernstein | Mkt Perform |
| Jan-03-23 | Downgrade | Jefferies | Buy → Underperform |
| Oct-26-22 | Downgrade | Deutsche Bank | Hold → Sell |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-27-22 | Upgrade | Jefferies | Underperform → Buy |
| Feb-11-22 | Downgrade | Jefferies | Hold → Underperform |
| Nov-23-21 | Initiated | HSBC Securities | Hold |
| Nov-11-21 | Upgrade | Jefferies | Underperform → Hold |
| Feb-04-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-03-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
| May-20-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-21-20 | Upgrade | Jefferies | Hold → Buy |
| Jun-20-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-26-18 | Upgrade | UBS | Neutral → Buy |
| Aug-28-18 | Upgrade | HSBC Securities | Hold → Buy |
| Jul-05-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Jan-04-18 | Upgrade | UBS | Sell → Neutral |
| Dec-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-06-16 | Upgrade | Citigroup | Neutral → Buy |
| Jul-08-16 | Upgrade | Jefferies | Underperform → Hold |
| Jan-04-16 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-04-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-03-15 | Upgrade | Goldman | Neutral → Buy |
| Aug-13-15 | Downgrade | Societe Generale | Buy → Hold |
| Jul-31-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-02-13 | Reiterated | Feltl & Co. | Hold |
| Jan-14-13 | Upgrade | HSBC Securities | Neutral → Overweight |
View All
Fresenius Medical Care Ag Adr Stock (FMS) Latest News
Here's Why Sandoz Group AG Sponsored ADR (SDZNY) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Weekly Upgrades and Downgrades - InvestorPlace
Hemodialysis and Peritoneal Dialysis Market to Surpass Valuation of USD 142.97 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Fresenius Medical Care Earnings: Margin Expansion Boosts 2024 Profit Outlook Toward Top End of Goal - Morningstar
Fresenius Medical Care ADR earnings beat by $0.35, revenue fell short of estimates - Investing.com India
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
2024 Healthcare Stocks List | Updated Daily - Sure Dividend
Saudi Arabia Generic Pharmaceutical Products Market Report 2024-2031, Featuring Profiles of Key Players - GlobeNewswire Inc.
FMS Stock Rides On Diversified Portfolio And Restructuring Initiatives - Barchart
Reasons to Retain Fresenius Medical Stock in Your Portfolio Now - Yahoo Finance
Australia Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Canada Clinical Laboratory Service Market Size & Outlook, 2030 - Grand View Research
Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar
The Best Healthcare Stocks to Buy - Morningstar
Expert Call - Fresenius Medical Care
Earnings call: Fresenius Medical Care sees steady progress in Q2 - Investing.com
Earnings call: Fresenius Medical Care confirms outlook, reports growth - Investing.com
Fresenius Medical Care Aims to Improve Its Margins Substantially - Morningstar
Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024 - Fresenius Medical Care
UK Clinical Laboratory Service Market Size & Outlook, 2030 - Grand View Research
Singapore Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Italy Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Fresenius Medical Care celebrates 50th anniversary of St. Wendel site - Fresenius Medical Care
Fresenius Medical Care Ag Adr Stock (FMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):